Stealth BioTherapeutics

About:

Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.

Website: http://www.stealthbt.com/

Twitter/X: StealthBT

Top Investors: Horizon Technology Finance, Morningside Venture Investments, Pivotal bioVenture Partners, Kingdon Capital, BVCF

Description:

Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. The company was founded in 2007 and is based in Newton, Massachusetts, United States.

Total Funding Amount:

$191M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Newton, Massachusetts, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)stealthbt.com

Founders:

Hazel Szeto

Number of Employees:

51-100

Last Funding Date:

2022-04-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai